jnt-517
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Oct 31, 2022 (NCT05781399)
Timeline
Indications
Studied for
Mechanism of action
- PhenylalanineBINDING AGENT
binding agent - phenylalanine
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06971731 | Phase 3 | Aug 31, 2025 | Otsuka |
| NCT06628128 | Phase 3 | Nov 30, 2024 | Jnana Therapeutics |
| NCT06637514 | Phase 2 | Nov 30, 2024 | Jnana Therapeutics |
| NCT05781399 | Phase 1 | Oct 31, 2022 | Jnana Therapeutics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jnana Therapeutics | For profit | 3 | 3 | 3 | 2022 |
| Otsuka | For profit | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1